Similar to the results from mouse gene disruption studies, B cells from SLE patients with seropositivity of anti-TRIM21 Ab also indicated significantly higher ability to differentiate into plasmablasts and to produce Ab as compared with controls. Here, TRIM21 is linked to systemic lupus erythematosus.